Advertisement

Are There Useful New Markers of Sepsis?

  • M. Meisner
  • K. Reinhart
Conference paper

Abstract

Severe infections and sepsis are common causes of morbidity and mortality in intensive care units. Clinical and laboratory signs of systemic inflammation such as changes in body temperature, leukocytosis, and tachycardia are frequently used for the diagnosis of infection or sepsis [1]. However, these signs and symptoms are neither specific nor sensitive for infection or sepsis. Various other and non-microbial infection related aetiologies of systemic inflammation may induce these symptoms. For example, patients suffering from pancreatitis, major trauma or burns present with a similar inflammatory response even in the absence of infectious complications. On the other hand, bacteriological evidence of infection, though definitive and specific, may not develop concurrently with clinical signs of sepsis.

Keywords

Septic Shock Severe Sepsis Systemic Inflammation Adult Respiratory Distress Syndrome Viral Meningitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–87CrossRefGoogle Scholar
  2. 2.
    Al-Nawas B, Shah PM (1996) Procalcitonin in patients with and without immunosuppression and sepsis. Infection 24:434–436PubMedCrossRefGoogle Scholar
  3. 3.
    Assicot M, Gendrel D, Carsin H et al (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341:515–518PubMedCrossRefGoogle Scholar
  4. 4.
    Berner R, Niemeyer CM, Leititis JU et al (1998) Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-alpha, interleukin (IL)-lbeta, IL-6, IL8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis. Pediatr Res 44:469–477PubMedCrossRefGoogle Scholar
  5. 5.
    Brunkhorst FM, Forycki ZF, Wagner J (1995) Discrimination of infectious and non-infectious etiologies of the adult respiratory distress syndrome (ARDS) with procalcitonin immunoreactivity. Clin Intens Care 6:3–3CrossRefGoogle Scholar
  6. 6.
    Brunkhorst FM, Heinz U, Forycki ZF (1998) Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med 24:888–889PubMedCrossRefGoogle Scholar
  7. 7.
    Chiesa C, Panero A, Rossi N et al (1998) Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis 26:664–672PubMedCrossRefGoogle Scholar
  8. 8.
    Dandona P, Nix D, Wilson MF et al (1994) Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 79:1605–1608PubMedCrossRefGoogle Scholar
  9. 9.
    Dev D, Wallace E, Sankaran R et al (1998) Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease. Respir Med 92:664–667PubMedCrossRefGoogle Scholar
  10. 10.
    De Werra I, Jaccard C, Corradin SB et al (1997) Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 25:607–613PubMedCrossRefGoogle Scholar
  11. 11.
    Eberhard OK, Haubitz M, Brunkhorst FM et al (1997) Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/ systemic antineutrophil cytoplasmatic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 40:1250–1256PubMedGoogle Scholar
  12. 12.
    Eberhard OK, Langefeld I, Kuse E et al (1998) Procalcitonin in the early phase after renal transplantation — will it add to diagnostic accuracy? Clin Transpl 12:206–211Google Scholar
  13. 13.
    Engel A, Mack E, Kern P, Kern WV (1998) An analysis of IL-8, IL-6 and CRP serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients. Infection 26:213–221PubMedCrossRefGoogle Scholar
  14. 14.
    Eriksson S, Granstrom L, Olander B, Wretlind B (1995) Sensitivity of interleukin-6 and C-reactive protein concentrations in the diagnosis of acute appendicitis. Eur J Surg 161:41–45PubMedGoogle Scholar
  15. 15.
    Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448–454PubMedCrossRefGoogle Scholar
  16. 16.
    Gendrel D, Raymond J, Assicot M et al (1998) Procalcitonin, C-reactive protein and interleukin 6 in bacterial and viral meningitis in children. Presse Med 27:1135–1139PubMedGoogle Scholar
  17. 17.
    Gramm H-J, Dollinger P, Beier W (1995) Procalcitonin — ein neuer Marker der inflammatorischen Wirtsantwort. Longitudinalstudien bei Patienten mit Sepsis und Peritonitis. Chir Gastroenterol 11 [Suppl 21 :51–54CrossRefGoogle Scholar
  18. 18.
    Hamano K, Gohra H, Noda H et al (1998) Increased serum interleukin-8: correlation with poor prognosis in patients with postoperative multiple organ failure. Word J Surg 22:1077–1081CrossRefGoogle Scholar
  19. 19.
    Hammer S, Meisner F, Dirschedl P et al (1998) Procalcitonin: a new marker for diagnosis of acute rejection and bacterial infection in patients after heart and lung transplantation. Transpl Immunol 6:235–241PubMedCrossRefGoogle Scholar
  20. 20.
    Kuse ER, Langefeld I, Jaeger K, Külpmann WR (1999) Procalcitonin in fever of unkown origin (FUO) following liver transplantation — a parameter to differentiate acute rejection from infection. Crit Care Med (in press)Google Scholar
  21. 21.
    Kutukculer N, Caglayan S, Aydogdu F (1998) Study of pro-inflammatory (TNF-alpha, ILlalpha, IL-6) and T cell-derived (IL-2, IL-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: correlations with clinical and laboratory parameters. Clin Rheumatol 17:288–292PubMedCrossRefGoogle Scholar
  22. 22.
    Malaguarnera M, Di Fazio I, Romeo MA et al (1997) Elevation of interleukin 6 levels in patients with chronic hepatitis due to hepatitis C virus. J Gastroenterol 32:211–215PubMedCrossRefGoogle Scholar
  23. 23.
    Meisner M, Tschaikowsky K, Palmaers T, Schmidt J (1999) Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 3:45–50PubMedCrossRefGoogle Scholar
  24. 24.
    Meisner M, Tschaikowsky K, Hutzler A et al (1998) Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 24:680–684PubMedCrossRefGoogle Scholar
  25. 25.
    Monneret G, Labaune JM, Isaac C et al (1997) Procalcitonin and C-reactive protein levels in neonatal infections. Acta Paediatr 86:209–212PubMedCrossRefGoogle Scholar
  26. 26.
    Nast-Kolb D, Waydhas C, Gippner-Steppert C et al (1997) Indicators of the posttraumatic inflammatory response correlate with organ failure in patients with multiple injuries. J Trauma 42:446–454PubMedCrossRefGoogle Scholar
  27. 27.
    Nylen ES, Whang KT, Snider RH et al (1998) Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 26: 1001–1006PubMedCrossRefGoogle Scholar
  28. 28.
    Oberhoffer M, Karzai W, Meier-Hellmann A et al (1999) Sensitivity and specifity of various markers of inflammation for the prediction of tumor necrosis factor and interleukin-6 in patients with sepsis. Crit Care Med (in press)Google Scholar
  29. 29.
    Oberhoffer M, Vogelsang H, Russwurm S et al (1999) Outcome prediction by traditional and new markers of inflammation in patients with sepsis. Clin Chem Lab Med 37:363–368PubMedCrossRefGoogle Scholar
  30. 30.
    Povoa P, Almeida E, Moreira P et al (1998) C-reactive protein as an indicator of sepsis. Intensive Care Med 24:1052–1056PubMedCrossRefGoogle Scholar
  31. 31.
    Rau B, Steinbach G, Gansauge F et al (1997) The role of procalcitonin and interleukin-8 in the prediction of infected necrosis in acute pancreatitis. Gut 41:832–840PubMedCrossRefGoogle Scholar
  32. 32.
    Reinhart K, Wiegand-Lohnert C, Grimminger F et al (1996) Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study. Crit Care Med 24:733–742PubMedCrossRefGoogle Scholar
  33. 33.
    Robak T, Gladalska A, Stepien H, Robak E (1998) Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis. Mediators Inflamm 7:347–353PubMedCrossRefGoogle Scholar
  34. 34.
    Schwenger V, Sis J, Breitbart A, Andrassy K (1998) CRP levels in autoimmune disease can be specified by measurement of procalcitonin. Infection 26:274–276PubMedCrossRefGoogle Scholar
  35. 35.
    Shenkin A, Fraser WD, Series J et al (1989) The serum interleukin 6 response to elective surgery. Lymphokine Res 8:123–127PubMedGoogle Scholar
  36. 36.
    Shaw AC (1991) Serum C-reactive protein and neopterin concentrations in patients with viral or bacterial infection. J Clin Pathol 44:596–599PubMedCrossRefGoogle Scholar
  37. 37.
    Ugarte H, Silva E, Mercan D (1999) Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 27:498–504PubMedCrossRefGoogle Scholar
  38. 38.
    Wakefield CH, Barclay GR, Fearon KC et al (1998) Proinflammatory mediator activity, endogenous antagonists and the systemic inflammatory response in intra-abdominal sepsis. Scottish Sepsis Intervention Group. Br J Surg 85:818–825PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2000

Authors and Affiliations

  • M. Meisner
  • K. Reinhart

There are no affiliations available

Personalised recommendations